• Product nameAnti-TACI antibody
    See all TACI primary antibodies
  • Description
    Rabbit polyclonal to TACI
  • Tested applicationsSuitable for: WB, IHC-P, Flow Cytmore details
  • Species reactivity
    Reacts with: Mouse, Human
    Predicted to work with: Chimpanzee
  • Immunogen

    Synthetic peptide:


    , corresponding to amino acids 116-132 of Human TACI

  • Positive control
    • Spleen tissue.



Our Abpromise guarantee covers the use of ab79023 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
Flow Cyt
  • Application notesFlow Cyt: Use at an assay dependent dilution.
    IHC-P: Use at a concentration of 5 µg/ml.
    WB: Use at a concentration of 5 µg/ml. Predicted molecular weight: 32 kDa.

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • FunctionReceptor for TNFSF13/APRIL and TNFSF13B/TALL1/BAFF/BLYS that binds both ligands with similar high affinity. Mediates calcineurin-dependent activation of NF-AT, as well as activation of NF-kappa-B and AP-1. Involved in the stimulation of B- and T-cell function and the regulation of humoral immunity.
    • Tissue specificityHighly expressed in spleen, thymus, small intestine and peripheral blood leukocytes. Expressed in resting B-cells and activated T-cells, but not in resting T-cells.
    • Involvement in diseaseDefects in TNFRSF13B are the cause of immunodeficiency common variable type 2 (CVID2) [MIM:240500]. CVID2 is a primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections and an inability to mount an antibody response to antigen. The defect results from a failure of B-cell differentiation and impaired secretion of immunoglobulins; the numbers of circulating B cells is usually in the normal range, but can be low.
      Defects in TNFRSF13B are a cause of immunoglobulin A deficiency 2 (IGAD2) [MIM:609529]. Selective deficiency of immunoglobulin A (IGAD) is the most common form of primary immunodeficiency, with an incidence of approximately 1 in 600 individuals in the western world. Individuals with symptomatic IGAD often have deficiency of IgG subclasses or decreased antibody response to carbohydrate antigens such as pneumococcal polysaccharide vaccine. Individuals with IGAD also suffer from recurrent sinopulmonary and gastrointestinal infections and have an increased incidence of autoimmune disorders and of lymphoid and non-lymphoid malignancies. In vitro studies have suggested that some individuals with IGAD have impaired isotype class switching to IgA and others may have a post-switch defect. IGAD and CVID have been known to coexist in families. Some individuals initially present with IGAD1 and then develop CVID. These observations suggest that some cases of IGAD and CVID may have a common etiology.
    • Sequence similaritiesContains 2 TNFR-Cys repeats.
    • Cellular localizationMembrane.
    • Information by UniProt
    • Database links
    • Alternative names
      • CD 267 antibody
      • CD267 antibody
      • CD267 antigen antibody
      • CVID antibody
      • CVID2 antibody
      • FLJ39942 antibody
      • MGC133214 antibody
      • MGC39952 antibody
      • OTTHUMP00000065442 antibody
      • TNFRSF 13B antibody
      • TNFRSF 14B antibody
      • TNFRSF13B antibody
      • TNFRSF13B protein antibody
      • TNFRSF14B antibody
      • TR13B_HUMAN antibody
      • Transmembrane activator and CAML interactor antibody
      • Tumor necrosis factor receptor 13B antibody
      • Tumor necrosis factor receptor superfamily member 13B antibody
      see all

    Anti-TACI antibody images

    • Immunohistochemical analysis of formalin-fixed, paraffin-embedded Human spleen tissue, staining TACI with ab79023 at 5 µg/ml.
    • Anti-TACI antibody (ab79023) at 0.1 µg/ml + Daudi cell lysate at 10 µg

      Predicted band size : 32 kDa

    References for Anti-TACI antibody (ab79023)

    ab79023 has not yet been referenced specifically in any publications.

    Product Wall

    I am sorry to hear that you have experienced difficulties with two of our products in the past. However, because we carry over 90,000 products, it isn't feasible for us to keep small sample sizes of our products.
    We are happy to reassure our custo...

    Read More